Improving health service monitoring of high-risk populations seeks to prevent new HIV infections
A new tool has been launched by the Pan American Health Organization (PAHO) that aims to help health services in Latin America and the Caribbean better monitor the health of those at high risk of contracting HIV in order to prevent the infection.
The ‘monitoring framework for HIV services for key populations' tool, launched at the 10th IAS Conference on HIV Science (IAS 2019) in Mexico City, is a new way of monitoring;... read more
Doctors sound alarm about rapidly spreading, deadly, drug-resistant fungus
A drug-resistant fungus discovered in Japan in 2009 is spreading around the world at an alarming rate.
Candida auris outbreaks often happen in hospitals and other places where those with weakened immune systems reside. The fungus can live on walls and other surfaces like furniture for weeks at a time, creating a major, yet invisible, threat.... read more
FDA approves first therapy for rare joint tumor
The U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery... read more
New Alzheimer's Blood Test 94% Accurate
A new blood test to detect brain changes suggestive of early Alzheimer's disease (AD) has moved one step closer to reality and could be a "game changer" for the field.
Researchers found that measuring the ratio of ß-amyloid (Aß) 42 and Aß40 in blood using a high-precision assay is 94% accurate in diagnosing brain amyloidosis, using amyloid PET or CSF phosphorylated (p-tau) 181/Aß42 as reference standards.... read more
New ADA Update: Liraglutide for Youth; Technology Issues
Updates to the American Diabetes Association's (ADA's) Living Standards of Medical Care in Diabetes incorporate the recent approval of liraglutide for youth with type 2 diabetes, new cardiovascular outcomes trial (CVOT) data for dulaglutide, and new consensus recommendations for "time-in-range" using continuous glucose monitoring (CGM).... read more